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Key points summary 
 Uterine artery vasodilatation is a key mechanism for increasing utero-
placental blood flow and fetal nutrient supply. 
 Since the pioneering work of Joseph Barcroft, the natural laboratory of high 
altitude has been used to study the mechanisms regulating uterine artery 
blood supply and fetal growth. 
 Genes near the metabolic sensor, adenosine monophosphate-activated 
protein kinase (AMPK), have been implicated in genetic protection from high 
altitude-associated fetal growth restriction. 
 We show that AMPK is present in utero-placental tissues, has vasodilator 
effects in murine uterine arteries, and that exposure to chronic hypoxia 
sufficient to decrease fetal growth increases the vasodilator actions of AMPK 
in opposing phenylephrine-induced vasoconstriction. 
 These results point to AMPK as being a key link between maternal vascular 
responses to pregnancy and fetal growth. Manipulation of AMPK may be a 
novel mechanism for developing new therapies in pregnancies complicated by 
chronic hypoxia.  
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Abstract 
Genes near PRKAA1 (adenosine monophosphate-activated protein kinase 
[AMPK] alpha-1) have been implicated in the greater uterine artery (UtA) blood flow 
and relative protection from fetal growth restriction seen in altitude-adapted, Andean 
populations. AMPK activation vasodilates multiple vessels but whether AMPK is 
present in UtA or placental tissue and influences UtA vasoreactivity during normal or 
hypoxic pregnancy remains unknown. We studied isolated UtA and placenta from 
near-term C57BL/6J mice housed in normoxia (n=8) or hypoxia (10% FiO2, n=7-9) 
from day 14-19, and placentas from non-labouring sea level (n=3) or 3100 m (n=3) 
women. Hypoxia increased AMPK immunostaining in near-term murine UtA and 
placental tissue. RT-PCR products for AMPK alpha-1 and alpha-2 isoforms and 
LKB1 (the upstream kinase activating AMPK) were present in murine and human 
placenta, and hypoxia increased LKB1, AMPK alpha-1 and alpha-2 expression in the 
high- compared with low-altitude human placentas. Pharmacological AMPK 
activation by A769662 caused phenylephrine pre-constricted UtA from normoxic or 
hypoxic pregnant mice to dilate and this dilatation was partially reversed by the NOS 
inhibitor L-NAME. Hypoxic pregnancy sufficient to restrict fetal growth markedly 
augmented the UtA vasodilator effect of AMPK activation in opposition to PE 
constriction as the result of both NO-dependent and NO-independent mechanisms. 
We concluded that AMPK is activated during hypoxic pregnancy and that AMPK 
activation vasodilates the UtA, especially in hypoxic pregnancy. AMPK activation 
may be playing an adaptive role by limiting cellular energy depletion and helping to 
maintain utero-placental blood flow in hypoxic pregnancy.  
Keywords: fetal growth restriction, high-altitude adaptation, nitric oxide, utero-
placental blood flow, phenylephrine  
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Abbreviations: AICAR, 5-amino-1-beta-D-ribofuranosyl-imadazole-4-carboxamide; 
AMPK, AMP-activated protein kinase; AUC, area under the curve; BKCA, large-
conductance potassium channel; BPD, biparietal diameter; DAB, 3, 3’-
diaminobenzidine; JZ, junctional zone; KCl, potassium chloride; LKB1, liver kinase 
B1, LZ, labyrinthine zone; mTOR, mechanistic target of rapamycin; NO, nitric oxide; 
NOS, nitric oxide synthase; PE, phenylephrine; PRKAA1, the gene coding for AMPK 
alpha-1 isoform; THR, threonine; UtA, uterine artery.  
Introduction 
Pioneering studies of Joseph Barcroft and his students drew attention to the 
value of high altitude as a natural laboratory for understanding the mechanisms by 
which intrauterine hypoxia reduces fetal growth (Barcroft, 1933; Barron et al., 1964). 
A key determinant of fetal growth is the pregnancy rise in uterine artery (UtA) blood 
flow, which is due, in turn, to profound changes in multiple physiological systems 
(Gant & Worley, 1989). Among the greatest are the structural remodelling and 
alterations in vasoreactivity of the uterine vasculature that result in approximately 
20% of the maternal cardiac output being directed to the utero-placental circulation 
by term (Osol & Moore, 2014). Isolated vessel studies in experimental animals show 
that chronic hypoxia is associated with a decreased vasodilator response to flow and 
to pharmacological agonists in the main UtA and downstream vessels (White et al., 
2000; Mateev et al., 2003; Xiao et al., 2010), which may, in turn, contribute to the 
reduced UtA blood flow and altitude-associated fetal growth restriction seen in high-
altitude newcomers (Zamudio et al., 1995; Julian et al., 2008). Multigenerational 
highland residents (Andeans and Tibetans) are relatively protected from altitude-
associated reductions in fetal growth and have a greater pregnancy rise in UtA blood 
flow compared with altitude newcomers (Moore et al., 1998; Giussani et al., 2001; 
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Moore et al., 2001; Chen et al., 2002; Julian et al., 2007; Julian et al., 2009; Soria et 
al., 2013). Such protection appears due, in part, to genetic factors given that it is 
proportional to the degree of highland ancestry and is not the result of the woman’s 
own duration of residence at high altitude (Bennett et al., 2008; Julian et al., 2011; 
Soria et al., 2013). 
Identifying the genes and signalling pathways involved in protecting native 
highlanders presents a novel means for addressing the mechanisms by which 
intrauterine hypoxia influences fetal growth. Several gene regions have been acted 
upon by natural selection in long-resident populations (Bigham et al., 2009; Beall et 
al., 2010; Bigham et al., 2010; Simonson et al., 2010; Yi et al., 2010; Alkorta-
Aranburu et al., 2012). In Andeans prominent among these are single nucleotide 
polymorphisms (SNPs) near PRKAA1 (adenosine monophosphate-activated protein 
kinase [AMPK] alpha-1) (Bigham et al., 2009; Bigham et al., 2010). Further, the 
AMPK alpha-1 variants more common in Andeans are positively associated with 
infant birth weight as well as with key determinants of fetal growth, namely the 
pregnancy-associated increase in UtA diameter and the expression patterns of 
genes in metabolic pathways proposed to play a role in altitude-associated fetal 
growth restriction (Yung et al., 2012; Bigham et al., 2014). 
AMPK is a ubiquitously expressed enzyme in eukaryotes, that is stimulated by 
stresses that deplete cellular ATP and thus serves as a metabolic sensor for 
matching tissue energy demand with supply (Hardie et al., 2012). It is comprised of 
three subunits (alpha, beta, gamma), each of which has multiple isoforms whose 
expression levels vary by tissue type (Viollet et al., 2010). The alpha-1 and alpha-2 
isoforms are the catalytic subunits and contain the Thr-172 site where AMPK is 
activated more than 100-fold via phosphorylation by LKB1 and other upstream 
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kinases (Evans et al., 2009; Viollet et al., 2009). In skeletal muscle AMPK activation 
promotes glucose uptake and mitochondrial biogenesis, and decreases energy 
demand by inhibiting the mechanistic target of rapamycin (mTOR) and switching on 
various catabolic enzymes (Hardie, 2011). More recently AMPK activation has been 
recognized to have vascular effects, acting to stimulate endothelial nitric oxide (NO) 
production (Wang & Proud, 2006) as well as to regulate smooth muscle function 
directly (Goirand et al., 2007). Underscoring its importance under conditions of 
hypoxia, AMPK activation has been implicated in the aetiology of early-onset pre-
eclampsia (Yung et al., 2014a) cardiorespiratory responses to hypoxia (Evans, 
2006), and hypoxic pulmonary vasoconstriction (Evans et al., 2005).   
It is unknown whether AMPK activation influences UtA vasoreactivity during 
pregnancy and, if so, whether such effects are altered by exposure to hypoxia. We 
used a broad-ranging approach to address such questions in which human as well 
as experimental-animal tissues were studied using multiple methods. Specifically, we 
hypothesized that AMPK is present in UtA and placental tissue and that its 
expression was increased during pregnancy by exposure to hypoxia as detected 
using immunohistochemistry in mice and quantitative RT-PCR in previously collected 
human tissues. We further hypothesized that AMPK activation prompted UtA 
vasodilation and/or altered vasoconstrictor sensitivity to phenylephrine (PE) in 
vessels isolated from near-term mice, and that such effects were altered by 
exposure to hypoxia. To test these hypotheses we used the pharmacological AMPK 
agonist A769662 and compared UtA vasodilator and vasoconstrictor responses in 
vessels isolated from the normoxic vs. hypoxic animals. Finally, we treated vessels 
with the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME) to determine the 
contribution of NO-dependent and  
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-independent mechanisms to the effects of AMPK activation observed. We 
considered that such studies would improve our understanding of the mechanisms 
regulating maternal vascular responses to pregnancy and fetal growth under 
conditions of chronic hypoxia.  
 
Methods 
Ethical Approval. All mouse experiments were carried out using procedures 
consistent with the UK Animals Scientific Procedures Act 1986 and approved by the 
Local Ethics Review Committee of the University of Cambridge. Placentas were 
collected from human subjects who provided written informed consent to procedures 
approved by the University of Colorado Multiple Institutional Review Board 
(COMIRB, Aurora, CO, USA), the University College Hospital London (London, UK), 
and the Cambridge Local Research Ethics Committee. 
Samples and Protocols. Female C57BL/6J mice were placed with males 
overnight. The presence of a copulatory plug the following morning was taken to 
indicate day one of pregnancy. Pregnant mice (n=31) were housed in groups of two 
or three in rooms with 21% O2, 12 hr light-dark cycles and controlled temperature 
(21°C) and humidity (60%). They had ad libitum access to food (Rat and Mouse No. 
3 Breeding, Special Diet Services, Witham, UK). At day 14 of pregnancy (term is ~ 
21 days), animals were randomly assigned to normoxic or hypoxic (10% O2) 
treatment groups. Hypoxia was achieved by placing the animals in a chamber 
containing a PVC isolator (PFI plastics Ltd) and a N2 generator (N2MID60, Domnick 
Hunter Ltd, UK) so as to control the percent O2 within the chamber, without changing 
the CO2 levels, by altering the inflows of air and N2. O2 levels were monitored using 
an O2 analyser (ICA, UK) and CO2 levels by a portable CO2 analyser that was 
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calibrated daily (The Electronic Workshop, Department of Physiology, Development 
and Neuroscience, University of Cambridge). Normoxic animals were housed in the 
same room that contained the chambers. Maternal weight, food and water intake 
were monitored daily.  This was achieved in the hypoxic group via a sealed transfer 
box that could be opened briefly without altering O2 levels within the main chamber.  
On day 19 of pregnancy mice were euthanized by cervical dislocation. The 
uterus was dissected immediately, the numbers of viable fetuses and fetal 
reabsorptions counted, fetal and placental weights recorded, and fetal biometry 
taken. Both UtA were removed, placed in ice cold PBS, and processed immediately 
(<5 min) for either myography or immunohistochemistry. In approximately half the 
normoxic and hypoxic animals, one placenta whose weight was closest to the litter 
mean was prepared for immunohistochemistry. 
Samples from human placentas were obtained from term, non-labouring 
women residing either at sea level (n=3) or high altitude (3100 m, n=3) as described 
previously (Yung et al., 2012).   
Immunohistochemistry. The murine uterine vessels were placed in ice cold 
PBS, cleared of adipose tissues and the uterine horn using a dissecting microscope 
(Leica, Germany), and fixed in 4% paraformaldehyde. The main UtA together with its 
1st and 2nd order branches was divided into 2-3 longitudinal segments, embedded in 
a single paraffin block, and sectioned. Whole placentas were washed with PBS, fixed 
in 4% paraformaldehyde, embedded in paraffin, and sectioned. Paraffin-embedded 
sections were de-waxed, washed, prepared for antigen retrieval using 0.01 M citric 
buffer (pH 6.0), and incubated overnight using either primary antibody (phospho-
AMPKα [Thr172] [40H9] rabbit) from Cell Signalling Technology (Hitchin, UK) diluted 
in 5% GS/HS in TBS or vehicle alone. The following day, the secondary antibody 
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(anti-rabbit IgG, diluted 1:200 in 5% GS/HS) was applied, incubated for 1 hr, 
developed for staining using DAB and counterstained with hematoxylin. The slides 
were scanned using a Nanozoomer (Hamamatsu Photonics, Welwyn Garden City, 
UK), saved as high-resolution files, and images quantified using IPLAb software 
(v6.0, Scanalytics, Fairfax, VA). DAB-positive areas were selected and segmented in 
a region of interest based on a selective distribution of saturation and hue values that 
matched the color of the DAB reactive product and the pattern of staining of the 
image. Segmented overlays representing the selected pixels of DAB staining were 
selected in individual UtA and the labyrinthine and junctional zones (separately), 
quantified and expressed as the percent area of positive DAB staining per area of 
tissue examined. 
Quantitative RT-PCR. RNA from mouse (n=3) or human (n=6) placental tissue 
was extracted using the miRNeasy Mini Kit from Qiagen (Manchester, UK) following 
the manufacturer’s guidelines, and the concentration determined using a Nanodrop 
1000 spectrophotometer (Thermo Scientific, Hemel Hempstead, UK). cDNA 
synthesis was carried out using the Transcriptor High Fidelity cDNA synthesis Kit 
(Roche, UK) following manufacturer instructions. For qPCR analysis, 2.5 µl of cDNA 
in RNase free water was made up to 25 µl with FastStart Universal SYBR Green 
Master (ROX, 12.5 µl, Roche), Ultra Pure Water (8 µl, SIGMA, UK) and forward and 
reverse primers for LKB1, AMPK alpha-1 and alpha-2 (Qiagen, UK). The sample 
was then centrifuged and 25 µl added to a MicroAmpTM Fast Optical 96-Well 
Reaction Plate (Greiner Bio-One, Stonehouse UK), the reaction plate sealed with an 
optical adhesive cover (Applied Biosystems, Warrington UK) and the plate 
centrifuged. The reaction was then run on a sequence detection system (Applied 
Biosystems) using AmpliTaq Fast DNA Polymerase with a 2 min initial step at 50oC 
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followed by a 10 min step at 95oC, a 15 sec step at 95oC (repeated 40 times) 
followed by a dissociation stage with a 15 sec step at 95oC, and followed by a 20 sec 
at 60oC and a 15 sec step at 95oC. Negative controls included tissue aspirants for 
which no reverse transcriptase was added, and aspiration of extracellular medium 
and PCR controls. None of the controls produced any detectable amplicon, ruling out 
genomic or other contamination.  
Myography. The murine uterine vasculature was dissected and pinned out in 
a dish of ice-cold Krebs solution (in mmol/L, all reagents from Sigma UK unless 
specified otherwise: NaCl 118.5, NaHCO3 25, KCl 4.75, MgSO4.7H2O 1.2, KH2PO4 
1.2, CaCl2 2.5, D-glucose 11.1). Using a bifocal dissecting microscope (Brunel 
Microscopes Ltd., UK), first-order 2 mm in length UtA segments were dissected and 
cleared of any connective or adipose tissue. The vessel segments were then 
mounted in a four-chamber, small-vessel wire myograph (Multi Wire Myograph 
System 620M, DMT, Denmark) by threading two wires 40 µm in diameter through 
the vessel lumen and attaching one to a pressure transducer and the other to a 
micrometer as previously described (Pulgar et al., 2011; Giussani et al., 2012). The 
chamber was continually gassed with 5% CO2 and 95% O2 to maintain a 
physiological pH, and gradually heated to 37°C. Throughout the investigation, the 
Krebs solution was refreshed every 20 min, and the vessels allowed to re-equilibrate 
for at least 20 min between experiments. 
UtA were normalised to 0.9 of L13.3 kPa, and allowed to equilibrate for 20 min. 
Following normalisation a ‘wake up’ protocol was performed consisting of exposure 
of the vessels to a high concentration of potassium (KCl, 125 mmol/L). Vessel 
viability was verified by a positive constrictor response to phenylephrine (PE, 1x10-4 
M) and a positive relaxant response to acetylcholine (ACh, 1x10-10 M to 1x10-4 M). 
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Two vessels from each animal were pre-constricted with a dose of PE determined to 
produce 70% of the maximal constriction to PE for each vessel. The sub-maximally 
pre-constricted vessels were then relaxed by addition of the AMPK agonist A769662 
(Tocris, USA) dissolved in DMSO in increasing concentrations (1x10-6 M to 1x10-4 M) 
at 10-min intervals, and the results from the two vessels per animal averaged. We 
chose A769662 because, unlike 5-amino-1-beta-D-ribofuranosyl-imidazole-4-
carboxamide (AICAR) or metformin, it activates AMPK directly, and not other 
enzymes that are responsive to AMP levels (Goransson et al., 2007). Another 
advantage is that A769662, unlike AICAR, is not taken up by the adenosine 
transporter and therefore does not lead to the accumulation of adenosine outside 
cells or necessitate the use of an adenosine antagonist (Goransson et al., 2007). A 
third and fourth vessel segment from each animal was also tested using increasing 
doses of PE (1x10-9 M – 1x10-4 M), with this then being repeated following 20 min 
incubation with A769662 (1x10-4 M) and finally repeated a third time following 
incubation with A769662 (1x10-4 M) plus the NOS inhibitor L-NAME (1x10-5 M). The 
finding that the third curve was consistently larger than the second provided 
reassurance that the response of the vessels was not deteriorating over time. 
Studies were completed in vessels from a total of 17 animals.  
Data and Statistical Analyses. The contractile response to PE was expressed 
as a percentage of the maximal constriction produced by KCl (% Kmax). The curves 
were fitted with the best-fit line for describing the response to a given agonist. The 
negative logarithm to base 10 of the dose at which vessels were 50% maximally-
constricted to PE (EC50 or pD2) was used as an index of vascular sensitivity, and the 
area under the curve (AUC) was calculated to assess overall reactivity using Prism 
v6.0 (GraphPad Software, La Jolla CA). Single values were compared between 
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normoxic and hypoxic groups using unpaired t-tests. Differences in immunostaining 
or mRNA expression between normoxic and hypoxic groups were assessed using 
one-way ANOVA with Student Neuman Keuls post hoc test. The effects of AMPK 
activation on PE-induced constriction were assessed using two-way ANOVA with 
Tukey post hoc test (Sigma Stat, Buckinghamshire, UK). Data are presented as the 
mean ± standard error of the mean (S.E.M.).  Significance was accepted when the 
two-tailed p<0.05 and reported as trends when 0.05<p<0.10. 
 
Results 
Maternal and fetal characteristics. Murine maternal body weights were similar 
at days 1 and 14, but reduced at day 19 in the hypoxic compared with normoxic 
groups (Table 1). Litter size was not reduced in the hypoxic group although there was 
a trend for a greater number of reabsorptions. Fetuses from hypoxic pregnancies 
weighed less but placental weights were similar to those seen in the normoxic group. 
Fetuses from the hypoxic compared with the normoxic group had smaller crown-
rump lengths, biparietal diameters (BPD) and a greater BPD to body weight ratio, 
indicating asymmetric growth restriction (Table 1).  
Placental and birth weights were similar for the non-labouring, sea-level or 
high-altitude women (Table 1), although birth weight was reduced at high altitude in 
the larger group of subjects from which these data were derived (Yung et al., 2012) 
Immunohistochemistry. The uterine vessels from normoxic mice 
demonstrated staining for phosphorylated (activated) AMPK in arteries of varying 
size. The hypoxic compared with normoxic animals had greater staining intensity 
with primary antibody (22.0% vs. 11.0% respectively, p<0.0001) whereas the 
staining intensity did not differ in the vessels from normoxic animals with and without 
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antibody (p=0.12), indicating minimal AMPK expression (Figure 1, left hand panels). 
Phosphorylated AMPK was also present in all regions of the mouse placenta (Figure 
1, right hand panels). Whereas staining intensity did not differ between the JZ and 
LZ of the placenta from normoxic animals (p=NS), hypoxic exposure markedly 
increased LZ relative to JZ staining (p<0.0001). 
Quantitative RT-PCR. Results from quantitative RT-PCR assays showed that 
mRNA for LKB1, AMPK alpha-1, and AMPK alpha-2 (as a % of -actin) were present 
in human and mouse placental tissue. Levels of RT-PCR products for LKB1 and both 
AMPK catalytic isoforms were greater in the tissues from the high-altitude compared 
with sea-level human placentas (Figure 2, top panel). In sea-level mouse placentas, 
AMPK alpha-2 levels were higher in the labyrinthine than junctional zones (Figure 2, 
bottom panel).  
Myography. The internal circumference of the isolated UtA at the time of study 
was similar in the normoxic and hypoxic murine groups (Table 1). There was no 
difference in the maximal contraction to KCl or PE, the contractile sensitivity to PE as 
measured by the pD2 (Table 1), or the relaxation response to ACh (10
-10 M to 10-4 M, 
p=NS, data not shown).  
A769662, an AMPK agonist, caused complete, concentration-dependent 
relaxation in the PE pre-constricted UtA and that relaxation was similar in the 
normoxic and hypoxic mice (Figure 3A). Inhibition of NOS by incubation with L-
NAME reduced the relaxation response to A769662 by 30% but did not fully reverse 
it, indicating that 70% was NO-independent in both the normoxic and hypoxic groups 
(Figure 3B).  
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Incubation with the AMPK agonist A769662 reduced UtA contractile sensitivity 
to PE in both the normoxic and hypoxic mice as demonstrated by the rightward shifts 
in the contractile concentration-response curves (Figure 4A-B), with the change due 
to A769662 being greater in the hypoxic than normoxic groups (Figure 4C). 
Treatment of the vessel with L-NAME increased contractile sensitivity to PE in 
vessels from normoxic or hypoxic mice (two-way ANOVA, both p<0.05), indicating 
that a portion of A769662’s effect in opposing PE-induced vasoconstriction was likely 
due to increased NO production or activity. However, L-NAME treatment did not fully 
reverse A769662’s effect, indicating that there was a NO-independent contribution 
as well. Moreover the NO-independent component was principally responsible for 
the greater vasodilator effect of AMPK activation seen in the vessels from hypoxic 
than normoxic animals (Figure 4D). 
 
Discussion  
Our principal findings were that AMPK was present in uterine arteries from 
near-term mice as well as in mouse and human placental tissue, and that AMPK 
expression was increased by hypoxia as judged by immunohistochemistry and 
mRNA expression. Consistent with the possibility that the LKB1-AMPK signalling 
pathway influenced vascular reactivity, we found that pharmacological activation of 
AMPK caused PE-preconstricted UtA from pregnant mice to relax due to both NO-
dependent and  
NO-independent mechanisms. While the vasodilator effect of AMPK activation was 
similar in UtA isolated from normoxic or hypoxic mice, AMPK activation more 
markedly opposed PE-induced constriction in the UtA from the hypoxic than the 
normoxic mice and this was due to NO-dependent but largely NO-independent 
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mechanisms. We therefore concluded that AMPK activation dilates uterine arteries, 
particularly in response to PE-induced vasoconstriction, and that this latter effect is 
enhanced by hypoxic pregnancy. 
AMPK activation in non-pregnant animals has chiefly been studied for its 
metabolic effects. Drugs such as metformin, which is widely prescribed for lowering 
glucose levels in individuals with type 2 diabetes, decrease hepatic glucose 
production by mildly inhibiting the mitochondrial respiratory chain complex I, which in 
turn activates AMPK (Viollet et al., 2012). In skeletal muscle, AMPK activation 
promotes glucose uptake and mitochondrial biogenesis, and decreases energy 
demand by inhibiting the mechanistic target of rapamycin (mTOR) or by switching on 
the expression of various catabolic enzymes (Hardie, 2011). More recently it has 
been recognized that AMPK activation also has vascular effects. Vessels express 
AMPK alpha-1 and alpha-2 isoforms; alpha-1 predominates in endothelial cells and 
both are present in vascular smooth muscle with their relative predominance varying 
by tissue type (Evans et al., 2005; Goirand et al., 2007; Matsumoto et al., 2008).  
AMPK activation has been shown to improve cardiac function in a rat model of 
chronic heart failure (Wang et al., 2011); to help initiate hypoxic pulmonary 
vasoconstriction (Evans et al., 2005); and to augment acetylcholine-induced 
relaxation in pre-constricted isolated thoracic aorta, mesenteric or resistance-sized 
cremaster arteries (Goirand et al., 2007; Ford & Rush, 2011). Importantly, the 
vascular effects of AMPK activation are not dependent on its metabolic effects 
(Bradley et al., 2010) or, as is the case with AICAR, the accumulation of adenosine 
(Evans et al., 2005; Goirand et al., 2007; Bradley et al., 2010) but rather are due to 
both NO-dependent and NO-independent mechanisms; namely, increased eNOS 
activity and NO production (Viollet et al., 2010), decreased superoxide and 
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vasoconstrictor prostanoid production (Matsumoto et al., 2008; Li et al., 2010), and 
direct actions in vascular smooth muscle (Goirand et al., 2007).  
Our data showing AMPK immunostaining in normoxic mouse uterine vessels 
and placenta tissue, and mRNA in murine and human placenta for both AMPK alpha 
isoforms and the upstream kinase responsible for activating AMPK, LKB1, in mouse 
and human placenta were consistent with prior reports showing that AMPK is 
expressed in placental tissue (Yung et al., 2012). This is, however, to the best of our 
knowledge the first report of its presence in murine uterine vessels during 
pregnancy. The UtA and other uterine vessels undergo profound changes during 
pregnancy, enlarging their diameters as the result of structural remodelling as well as 
increased vasodilator responses to flow, acetylcholine and other pharmacological 
agonists (reviewed in (Osol & Moore, 2014)). Such changes are attributable to 
effects of oestrogen and other pregnancy hormones serving to increase the 
production and/or activity of various vasodilators, including NO and large-
conductance potassium channels (BKCA), rather than placentation per se since the 
changes begin before placentation is complete, occur even in ectopic pregnancy, 
and are present albeit to a lesser degree in pseudo-pregnant animals (Burchell, 
1967; Rosenfeld et al., 1996; van der Heijden et al., 2005; Collins et al., 2011; Hu et 
al., 2011). The present report shows for the first time that uterine arteries are relaxed 
by AMPK activation, suggesting that activation of AMPK may be another mechanism 
contributing to pregnancy vasodilatation. The vasorelaxant effects of AMPK 
activation were due, in part, to increased NO production or activity as shown by the 
effect of NOS inhibition but the major portion of its vasorelaxant effect remained 
following NOS inhibition, indicating that additional NO-independent mechanisms are 
involved. One possibility is that AMPK activation reduced the production of 
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vasoconstrictor prostanoids, similar to what has been reported in mesenteric arteries 
following metformin treatment in a rat model of type 2 diabetes (Matsumoto et al., 
2008). Direct effects on vascular smooth muscle cells may also be involved via 
actions on the RhoA-Rho associated protein kinase (Rock) pathway (Gayard et al., 
2011) or via K+ channels given that AMPK activation affects multiple K+ channels 
(Andersen & Rasmussen, 2012), including the BKCA and the ATP-sensitive 
potassium channel (KATP), previously implicated in uterine vascular responses to 
pregnancy and hypoxia (Zhu et al., 2013). Thus further study is required in both non-
pregnant and pregnant animals to determine whether pregnancy influences the 
effects of AMPK activation on UtA vasoreactivity, and the endothelial as well as 
vascular smooth muscle mechanisms involved.  
Little is known about the effects of AMPK activation under conditions of 
hypoxia.  Suggesting a beneficial role, Davidge and co-workers have shown that 
resveratrol, which works in part by activating AMPK (Hardie, 2011; Tennen et al., 
2012), administered to the mother under conditions of severe hypoxia dramatically 
improved fetal survival and increased placental relative to fetal weight but not fetal 
growth per se (Bourque et al., 2012; Banek et al., 2013). Resveratrol treatment also 
increased UtA blood flow velocity and fetal weight in a catechol-O-methyltransferase 
knockout mouse model of fetal growth restriction, but vasodilator or vasoconstrictor 
responses of isolated UtA were unaffected (Poudel et al., 2013). Resveratrol has 
also been shown to augment UtA blood flow during pregnancy in nonhuman 
primates (Roberts et al., 2014). 
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We found that hypoxia in late murine pregnancy sufficient to decrease fetal 
growth increased the intensity of AMPK immunostaining in the labyrinthine zone, 
which may be more sensitive to hypoxia given its rich blood supply in contrast to the 
relatively hypovascularized junctional zone (Dilworth & Sibley, 2013).  AMPK alpha-2 
mRNA expression was also greater in the labyrinthine than the junctional zone of the 
mouse placenta, suggesting that it may be the isoform involved in the greater 
immunostaining but differences in primer efficiency prevent comparison of LKB1, 
AMPK alpha-1 and alpha-2 expression levels. In humans, the levels of RT-PCR 
products for both AMPK alpha subunits and LKB1 were greater in the placentas from 
high- vs. low-altitude residents, suggesting higher basal AMPK activity and / or 
increased capacity to respond to metabolic stress. However, while these same 
placentas showed evidence of endoplasmic reticulum (ER) stress and mTOR 
inhibition, the ratio of P-AMPK to total AMPK was not consistently elevated in the 
small number (n=3) of non-labouring placentas available for study (Yung et al., 
2012). In pre-eclamptic women, the ratio of P-AMPK to total AMPK protein levels 
was inversely correlated with gestational age, being highest in those with the earliest 
onset of disease, although not higher overall in early- (<34 wk) vs. late (> 34 wk) 
onset pre-eclamptic or normotensive women (Yung et al., 2014b). Thus, further 
studies in larger numbers of placentas are required to determine if AMPK is activated 
at high vs. low altitude in placental tissue.  
We were interested in the effect of AMPK activation on UtA vasoreactivity 
under conditions of hypoxia given our prior studies indicating that the gene region 
containing AMPK alpha-1 has been acted upon by natural selection in Andean 
residents of high altitude and that the variants more common in Andeans were 
positively associated with birth weight, UtA diameter and alterations in the 
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expression of genes in the mTOR pathway previously implicated in altitude-
associated fetal growth restriction (Bigham et al., 2009; Yung et al., 2012; Bigham et 
al., 2014). The increased intensity of immunostaining in the mouse uterine arteries 
suggested that hypoxia increased AMPK abundance. However, since the antibody 
employed detects both alpha-1 and alpha-2 isoforms, we were not able to determine 
which isoforms were present in the uterine vessels.  
Based on previous studies in pulmonary and uterine arteries, we expected 
that AMPK activation would have less vasodilator effect in the UtA isolated from the 
hypoxic vs. normoxic animals. In pulmonary arteries, AMPK activation under 
conditions of acute (< 60 min) hypoxia prompted vasoconstriction through 
mobilization of myocyte sarcoplasmic reticulum calcium stores via ryanodine 
receptors and the release of an endothelium-derived constrictor (Evans, 2006). 
Inhibitory effects of AMPK activation on BkCA channels have also been observed, 
and in a manner that is splice-variant specific (Wyatt et al., 2007; Ross et al., 2011). 
It is notable, therefore, that BkCA channels are inhibited in resistance-sized ovine 
uterine vessels and, in turn, reverse the normal pregnancy reduction in myogenic 
tone (Hu et al., 2012). Further, we have reported that hypoxia throughout pregnancy 
reduced the NO-dependent UtA vasodilator response to ACh and flow in isolated 
guinea pig UtA (White et al., 2000; Mateev et al., 2003). Therefore, our finding that 
pharmacological AMPK activation prompted similar concentration-dependent 
vasodilation in preconstricted UtA from normoxic and hypoxic animals was 
somewhat surprising. Since maximal contraction to PE tended (p=0.07) to be greater 
in the hypoxic than the normoxic group and in order to evaluate the relationship 
between AMPK activation and PE constriction more fully, we extended our study to 
examine the effect of AMPK activation on contractile sensitivity to PE. We found that 
  
This article is protected by copyright. All rights reserved.   20 
 
AMPK activation markedly reduced UtA contractile sensitivity to PE in the UtA from 
the hypoxic compared with normoxic animals as demonstrated by a rightward shift in 
the contractile-response curves. The shift was greater in the vessels from the 
hypoxic compared to normoxic animals, and was partly reversed by treatment with 
the NOS inhibitor L-NAME, suggesting a role for NO in opposing PE-induced of 
constriction. While we cannot rule out the possibility that hypoxic exposure increased 
NO sensitivity, this appeared unlikely given that the relaxation in response to ACh or 
A769662 was not greater in the UtA from the hypoxic compared to normoxic 
animals. In addition, even though the NO component was larger in the hypoxic 
group, the major portion of the greater reduction in contractile sensitivity to PE was 
NO-independent. We therefore concluded that greater AMPK activation under 
conditions of hypoxic pregnancy opposes PE-induced vasoconstriction, thus perhaps 
serving as a compensatory mechanism for maintaining uterine artery blood flow. 
Further studies are required for determining the mechanisms by which AMPK 
activation opposes PE-induced vasoconstriction and whether similar effects of AMPK 
activation are observed when hypoxia is present throughout gestation such as is the 
case in residents of high altitude.  
The strengths of our study were its broad-ranging design in which human as 
well as murine tissues were examined following exposure to normoxia and either 
shorter- or longer-term hypoxia. Further, multiple methods were used to evaluate the 
effects of AMPK activation and hypoxia; namely, immunohistochemistry, quantitative 
RT-PCR and myography. Our results, however, were limited by use of a single 
AMPK activator. While A769662, unlike other agonists, activates AMPK directly 
(Goransson et al., 2007), it too has indirect effects by, for example, inhibiting the 
sodium pump (Benziane et al., 2009). While we used only one agonist, our results 
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were similar to those obtained using metformin, AICAR or exercise to activate 
AMPK, and thus suggested that the responses observed were the result of AMPK 
activation and not some other effect of the agonist employed (Goirand et al., 2007; 
Ford & Rush, 2011; Wang et al., 2011; Kroller-Schon et al., 2012) but additional 
studies using other agonists are required to confirm the mechanisms of A769662 
action. Further studies are also needed using western blot to document AMPK 
activation, knock-out mice for clarifying the roles of the AMPK alpha-1 and AMPK 
alpha-2 isoforms, and pair-fed animals to control for the lesser maternal weight gain 
seen during the period of hypoxic exposure in the present report. The possible effect 
of duration of hypoxic exposure also requires evaluation since the late-pregnancy 
onset employed here does not parallel the circumstances of residence at high 
altitude where hypoxia is present throughout gestation but, on the other hand, it does 
likely resemble that occurring with pre-eclampsia. 
In summary, AMPK is present in maternal uterine vessels as well as in 
placental tissues, and its abundance increased by short- as well as longer-term 
hypoxia as indicated by greater immunostaining in uterine vessels from pregnant 
mice and increased expression of both catalytic AMPK subunits in murine and 
human placenta. This is, to our knowledge, the first report that pharmacological 
AMPK activation prompts vasodilatation in UtA via both NO-dependent and NO-
independent mechanisms, and that exposure to chronic hypoxia sufficient to restrict 
fetal growth markedly augmented the ability of AMPK activation to oppose PE-
induced vasoconstriction. Together with prior reports that genetic variation near 
AMPK is related to increased UtA blood flow and maintenance of fetal growth in 
high-altitude adapted Andeans, we speculate that AMPK activation may be helping 
to maintain utero-placental blood flow and thereby limit cellular energy depletion. In 
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addition to its role as a metabolic sensor, AMPK may be a key link between maternal 
metabolic and cardiovascular responses to pregnancy and the regulation of fetal 
growth.  
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Figure 1. Phosphorylated AMPK (brown staining) is present in uterine arteries (UtA) 
and placentas from normoxic mice and increased by hypoxia in the UtA and the 
placental labyrinthine (LZ) but not junctional (JZ) or the decidua (DEC) zones. For 
the placenta specimens, panels A and B are with and without AMPK antibody, 
respectively, at 5x and panels C and D are with AMPK antibody at 20x magnification. 
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Figure 2. Upper Panel: mRNA for both AMPK alpha subunits and LKB1 are present 
at higher levels in human placentas from 3100 m vs. sea level. Lower Panel: Murine 
placentas also contain both AMPK alpha subunits and LKB1 at sea level, with 
expression levels for the alpha-2 subunit being greater in the labyrinthine than 
junctional zone. *=p<0.05, **=p<0.01, ****=p<0.0001. Data are mean + sem. 
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Figure 3.  Panel A: Uterine arteries pre-constricted with a submaximal dose of PE 
from normoxic (n=5) and hypoxic (n=7) pregnant (day 19) mice relax in response to 
increasing concentrations of the AMPK agonist, A769662.  Panel B: The area under 
the curve (AUC), representing nitric oxide (NO)-dependent and -independent 
components did not differ in the normoxic and hypoxic groups.  Data are mean + 
sem. 
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Figure 4.  Incubation with A769662 (1x10-4M, open circles, dotted lines) decreased 
contractile sensitivity to phenylephrine (PE) in UtA from both normoxic (panel A, n=8) 
and hypoxic (panel B, n=6-7) pregnant mice compared to values obtained prior to 
incubation with A769662 (open circles, solid lines). This decrease was significant in 
both groups when expressed as the area under the curve (AUC) (panel C, p<0.05, 
two way ANOVA and post-hoc Tukey test). The AUC, representing the change in 
sensitivity to PE following incubation with A769662, was significantly greater in the 
hypoxic compared to the normoxic animals (panel C, p<0.05, unpaired t-test). 
Treatment with L-NAME (1x10-5 M, black boxes and dashed lines) decreased the 
contractile response to PE in A769662-treated vessels from normoxic (A) and 
hypoxic (B) pregnant mice, indicating a significant NO-dependent component (both 
p<0.05), but did not fully restore the contractile response. The contributions of both 
nitric oxide (NO)-dependent and -independent mechanisms as well as the total 
relaxation response were greater in the UtA from hypoxic compared with normoxic 
animals (panel D, p<0.05, unpaired t-test).  
* = p<0.05. Data are mean + sem. 
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Table 1.  Characteristics of the murine and human subjects.  
Variable Normoxic group Hypoxic group  P value 
Mice: 
Sample size 8 7-9  
Maternal body weight, gm                 day  1 26.4 ± 1.8 26.2 ± 0.8 0.89 
day 14 31.9 ± 2.2 31.8 ± 0.8 0.93 
day 19 37.4 ± 3.0 32.5 ± 1.1 0.046 
Litter size, n 6.0 ± 1.1 6.6 ± 0.4 0.59 
Reabsorptions, n 0.4 ± 0.2 1.2 ± 0.4 0.06 
Fetal weight, mg 1101.6 ± 11.0 816.2 ± 36.3 <0.0001 
Placental weight, mg 101.4 ± 7.5 95.5 ± 3.8 0.42 
Fetal crown-rump length, mm 18.2 ± 0.3 16.3 ± 0.4 0.002 
Fetal biparietal diameter, mm 5.4 ± 0.2 4.8 ± 0.1 0.03 
Fetal biparietal diameter/weight 0.49 ± 0.02 0.58 ± 0.02 0.006 
 847.6 ± 34.1 911.8 ± 39 0.21 
 1.08 ± 0.2 0.79 ± 0.1 0.20 
 124.8 ± 11.8 166.2 ± 17.5 0.07 
PD2, M 6.8 ± 0.29 7.1 ± 0.3 0.50 
PE+A769662 pD2 without L-NAME, M 5.7 ± 0.17 5.2 ± 0.1 0.045 
 PE+A769662 pD2 with L-NAME, M 5.9 ± 0.16 5.6 ± 0.2 0.32 
Human subjects:    
Sample size 3 3  
Placental weight, gm 670 + 118 530 + 35 0.33 
Infant birth weight, gm 3813 + 104 3263 + 502 0.58 
Infant gestational age, wk 39.2 ± 1.4 39.8 ± 1.7 0.78 
Values are means + sem.  Bolded p values are <0.05.   
Abbreviations: KCl = potassium chloride, L-NAME = Nω-Nitro-L-arginine methyl ester 
hydrochloride, PE = phenylephrine, pD2 = negative logarithm to base 10 of the EC50 or the 
dose at which 50% of the maximal contraction was achieved. 
